サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1764952

北米の末梢塞栓用コイルの2031年までの市場予測-地域別分析-タイプ、材料、用途別

North America Peripheral Embolization Coils Market Forecast to 2031 - Regional Analysis - by Type, Material, and Application

出版日
ページ情報
英文 107 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.05円
北米の末梢塞栓用コイルの2031年までの市場予測-地域別分析-タイプ、材料、用途別
出版日: 2025年04月14日
発行: The Insight Partners
ページ情報: 英文 107 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の末梢塞栓用コイル市場は、2023年に2億4,786万米ドルと評価され、2031年には3億6,053万米ドルに達すると予測され、2023～2031年のCAGRは4.8%と推定されます。

大動脈瘤欠損の有病率の上昇が北米の末梢塞栓用コイル市場を促進

大動脈瘤は身体の主要な動脈または大動脈の壁が膨らんだものです。米国心臓協会の2023年のデータによると、大動脈瘤は2020年に世界中で報告された150,000人の死亡の原因であり、2010年から26％増加しています。喫煙者と女性では動脈瘤破裂の割合が高かったです。現在のところ、大動脈瘤の開発を予防する有効な薬剤はなく、唯一の治療選択肢は外科手術か血管内修復術です。塞栓剤は開腹手術の代用として頻繁に使用されているが、開腹手術はリスクが高く、回復に要する期間も長いです。末梢血管塞栓用コイル、シアノアクリレートまたはフィブリン接着剤、ゲルフォーム、Onyxなどが大動脈瘤からのエンドリークの治療によく使用される塞栓器具です。コイリングは開腹手術による修復よりも侵襲が少ないので、末梢動脈瘤に適した治療法です。コイルはまた、一部の先天性心疾患、瘻孔、動脈瘤、冠動脈バイパス術後の動脈側枝ステイル症候群の治療のために、選択的な場面で使用されることもあります。したがって、大動脈瘤の有病率の上昇が末梢塞栓用コイル市場の成長を牽引しています。

北米の末梢塞栓用コイル市場概要

北米の末梢塞栓用コイル市場は、米国、カナダ、メキシコの市場シナリオに基づいて分析されています。大腸がんと外傷の急増がこの地域の市場成長を促進する主要因です。大腸がんはメキシコで4番目に罹患率の高いがんであり、ほとんどの症例は50歳以降に報告され、症例の分布は性ともに同程度です。その結果、平均寿命の伸びとともに新規症例数と死亡率は着実に上昇しています。米国の末梢塞栓用コイル市場は、末梢動脈疾患（PAD）や動脈瘤などの血管疾患の有病率が増加しており、低侵襲な治療オプションが必要とされていることから成長を遂げています。末梢塞栓用コイルは、血管を塞いで出血を予防したり、標的部位の血流を減少させたりするのに不可欠です。ヘルスケアプロバイダがより低侵襲な処置で患者の予後を改善することに注力する中、これらのコイルに対する需要は高まっています。より効率的で生体適合性の高いコイルの開発などの技術進歩が、血管内治療に対する意識の高まりとともに、米国での市場拡大をさらに後押ししています。

メキシコではがん罹患率が上昇しており、大腸がんは診断頻度の高いがんの第3位にランクされています。IMSSによると、同国では毎年約15,000人の結腸がん患者が新たに登録されています。メキシコの大腸がん市場は、がんの早期発見キャンペーンを強化するために成長すると予想されます。GLOBOCANによると、メキシコにおける2020年の胃がん罹患率は6.2％、死亡率は10万人当たり4.7人です。マイクロコイル塞栓術は、上部消化管出血に対して確立された治療法であり、出血部位により近い場所で行うことができます。超選択的カテーテルを用いて行われる手技は、急性下部消化管出血を管理する安全で効果的な方法です。Statistaによると、2021年にカナダで発生した10万人あたり600件の入院は外傷が原因でした。Canadian Journal of Surgery（CJS）が2021年に発表した紙製によると、経動脈的塞栓術は脾臓以外の外傷の治療に成功しています。これらの手技は成功率が高く、合併症の発生率も低いです。さらに、カナダ保健省は頭蓋内動脈瘤の治療に多数のコイルとコイル送達システムを承認しています。コイル塞栓術は、ステントやバルーンなどの他の血管内治療補助器具と併用されます。

北米の末梢塞栓用コイル市場の収益と2031年までの予測（金額）

北米の末梢塞栓用コイル市場セグメンテーション

北米の末梢塞栓用コイル市場は、タイプ、材料、用途、国に分類されます。

タイプ別では、北米の末梢塞栓用コイル市場は着脱式コイルとプッシャブルコイルに二分されます。2023年には着脱式コイルセグメントが大きな市場シェアを占めています。

材料別では、北米の末梢塞栓用コイル市場はプラチナ、プラチナ&ハイドロゲル、プラチナタングステン合金に分類されます。2023年にはプラチナセグメントが最大の市場シェアを占めています。

用途別では、北米の末梢塞栓用コイル市場は出血・外傷、奇形、腫瘍、内臓動脈瘤、エンドリークII型、静脈瘤に区分されます。出血＆外傷セグメントが2023年に最大の市場シェアを占めました。

国別では、北米の末梢塞栓用コイル市場は米国、カナダ、メキシコに区分されます。2023年の北米の末梢塞栓用コイル市場シェアは米国が独占しました。

Medtronic Plc、Penumbra, Inc.、Balt、Boston Scientific Corp、Cook Medical Holdings LLC、Wallaby Medical、Spartan Micro Inc.、Terumo Corp.などが北米の末梢塞栓用コイル市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察
  • 市場の魅力

第3章 調査手法

  • 二次調査
  • 一次調査
    • 仮説の策定
    • マクロ経済要因分析
    • ファンデーション数値の開発
    • データの三角測量
    • 国レベルのデータ

第4章 北米の末梢塞栓用コイル市場：主要市場力学

  • 市場促進要因
    • 大動脈瘤の有病率の上昇
    • がんの発生率の増加
  • 市場抑制要因
    • 塞栓術の実施中または実施後に発生する合併症
  • 市場機会
    • 塞栓用コイルの応用範囲の拡大
  • 今後の動向
    • 充填密度の重要性の高まり
  • 促進要因と抑制要因の影響

第5章 末梢塞栓用コイル市場：北米の分析

  • 北米の末梢塞栓用コイル市場概要
  • 末梢塞栓用コイルの市場収益（2021～2031年）
  • 末梢塞栓用コイルの市場予測分析
  • 末梢塞栓用コイル市場企業のポジショニング

第6章 北米の末梢塞栓用コイル市場分析-製品タイプ別

  • イントロダクション
  • 着脱式コイル
  • プッシャブルコイル

第7章 北米の末梢塞栓用コイルの市場分析-材料別

  • イントロダクション
  • プラチナ
  • プラチナ＆ハイドロゲル
  • 白金タングステン合金

第8章 北米の末梢塞栓用コイルの市場分析-用途別

  • イントロダクション
  • 出血・外傷
  • 奇形
  • 腫瘍
  • 内臓動脈瘤
  • エンドリークII型
  • 静脈瘤

第9章 北米の末梢塞栓用コイル市場：国別分析

  • 北米の概要
    • 北米
      • 米国
      • カナダ
      • メキシコ

第10章 末梢塞栓用コイル市場：産業情勢

  • イントロダクション
  • 末梢塞栓用コイル市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第11章 企業プロファイル

  • Medtronic Plc
  • Penumbra, Inc.
  • Balt
  • Boston Scientific Corp
  • Cook Medical Holdings LLC
  • Wallaby Medical
  • Spartan Micro Inc.
  • Terumo Corp

第12章 付録

図表

List Of Tables

  • Table 1. North America Peripheral Embolization Coils Market Segmentation
  • Table 2. Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. United States: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 4. United States: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
  • Table 5. United States: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 6. Canada: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 7. Canada: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
  • Table 8. Canada: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 9. Mexico: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 10. Mexico: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
  • Table 11. Mexico: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 12. Recent Inorganic Growth Strategies in the Peripheral Embolization Coils Market
  • Table 13. Recent Organic Growth Strategies in the Peripheral Embolization Coils Market
  • Table 14. Glossary of Terms, Peripheral Embolization Coils Market

List Of Figures

  • Figure 1. North America Peripheral Embolization Coils Market Segmentation, by Country
  • Figure 2. Peripheral Embolization Coils Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Peripheral Embolization Coils Market Revenue (US$ Million), 2021-2031
  • Figure 5. Company Positioning
  • Figure 6. Peripheral Embolization Coils Market Share (%) - by Product Type (2023 and 2031)
  • Figure 7. Detachable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Pushable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Peripheral Embolization Coils Market Share (%) - by Material (2023 and 2031)
  • Figure 10. Platinum: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Platinum & Hydrogel: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Platinum Tungsten Alloy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Peripheral Embolization Coils Market Share (%) - by Application (2023 and 2031)
  • Figure 14. Bleedings & Trauma: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Malformations: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Tumors: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Visceral Aneurysms: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Endoleak Type II: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Varicose Veins: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. North America: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. North America: Peripheral Embolization Coils Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 22. United States: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Canada: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Mexico: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 25. Growth Strategies in the Peripheral Embolization Coils Market
目次
Product Code: BMIRE00031510

The North America peripheral embolization coils market was valued at US$ 247.86 million in 2023 and is expected to reach US$ 360.53 million by 2031; it is estimated to register a CAGR of 4.8% from 2023 to 2031.

Rise in Prevalence of Aortic Aneurysm Loss Fuels North America Peripheral Embolization Coils Market

An aortic aneurysm is a bulging wall of the body's major artery or aorta. According to the American Heart Association's 2023 data, aortic aneurysms were the cause of 150,000 fatalities reported across the world in 2020, indicating a 26% rise from 2010. Smokers and women had greater rates of aneurysmal rupture. Currently, there are no effective medications to prevent the development of aortic aneurysms; the only treatment options are surgical or endovascular repair. Embolization agents are frequently used as substitutes for open surgeries, which are riskier and followed by longer recovery periods. Peripheral vascular embolization coils, cyanoacrylate or fibrin glue, gel foam, and Onyx are among the embolic devices that are commonly used to treat endoleaks from aortic aneurysms. Coiling is a suitable therapy option for peripheral aneurysms since it is less invasive than open surgical repair. Coils can also be used in elective settings to treat some congenital cardiac diseases, fistulas, aneurysms, and arterial side branch steal syndrome after coronary artery bypass grafting. Therefore, an upsurge in the prevalence of aortic aneurysms drives the growth of the peripheral embolization coils market.

North America Peripheral Embolization Coils Market Overview

The peripheral embolization coils market in North America has been analyzed based on the market scenarios in United States, Canada and Mexico. An upsurge in the prevalence of colorectal cancer and trauma is a prime factor propelling market growth in this region. Colorectal cancer is the fourth most prevalent cancer in Mexico, with most cases reported after the age of 50, with a comparable distribution of cases in both genders. As a result, the number of new cases and rate of mortality have steadily climbed alongside the rising life expectancy. The peripheral embolization coil market in the United States is experiencing growth due to the increasing prevalence of vascular diseases, such as peripheral artery disease (PAD) and aneurysms, requiring minimally invasive treatment options. Peripheral embolization coils are essential for including blood vessels to prevent hemorrhage or reduce blood flow in targeted areas. As healthcare providers focus on improving patient outcomes with less invasive procedures, the demand for these coils is rising. Technological advancements, such as the development of more efficient and biocompatible coils, along with growing awareness of endovascular treatments, are further driving market expansion in the United States.

Cancer incidences are rising in Mexico, and colorectal cancer is ranked as the third most frequently diagnosed cancer. According to IMSS, every year approximately 15,000 new cases are registered with colon cancer in the country. The market for colorectal cancer in Mexico is expected to grow to increase the campaign for early detection of cancers. According to GLOBOCAN, in Mexico, the incidence rate of gastric cancer was 6.2% in 2020, with a mortality rate of 4.7 per 100,000 persons. Microcoil embolization is a well-established treatment for upper gastrointestinal bleeding that can be performed closer to the bleeding site. The procedure performed using a superselective catheter is a safe and effective way of managing acute lower gastrointestinal bleeding. According to Statista, trauma was the reason for ~600 per 100,000 hospitalizations in Canada in 2021. According to an article published by the Canadian Journal of Surgery (CJS) in 2021, transarterial embolization procedures are successfully being used to treat non-splenic traumatic injuries; the most common embolization technique is coiling with gel foam. These procedures have high success rates with low rates of complications. Moreover, Health Canada has approved numerous coils and coil delivery systems for the treatment of intracranial aneurysms. Coil embolization is used with other adjunct endovascular devices, such as stents and balloons.

North America Peripheral Embolization Coils Market Revenue and Forecast to 2031 (US$ Million)

North America Peripheral Embolization Coils Market Segmentation

The North America peripheral embolization coils market is categorized into type, material, application, and country.

Based on type, the North America peripheral embolization coils market is bifurcated into detachable coil and pushable coil. The detachable coil segment held a larger market share in 2023.

In terms of material, the North America peripheral embolization coils market is categorized into platinum, platinum & hydrogel, and platinum tungsten alloy. The platinum segment held the largest market share in 2023.

By application, the North America peripheral embolization coils market is segmented into bleedings & trauma, malformations, tumours, visceral aneurysm, endoleak type II, and varicose veins. The bleedings & trauma segment held the largest market share in 2023.

Based on country, the North America peripheral embolization coils market is segmented into the US, Canada, and Mexico. The US dominated the North America peripheral embolization coils market share in 2023.

Medtronic Plc; Penumbra, Inc.; Balt; Boston Scientific Corp; Cook Medical Holdings LLC; Wallaby Medical; Spartan Micro Inc.; and Terumo Corp. are some of the leading companies operating in the North America peripheral embolization coils market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. North America Peripheral Embolization Coils Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rise in Prevalence of Aortic Aneurysm
    • 4.1.2 Increase in Incidence of Cancer
  • 4.2 Market Restraints
    • 4.2.1 Complications Arising During or After Embolization
  • 4.3 Market Opportunities
    • 4.3.1 Expanding Range of Applications of Embolization Coils
  • 4.4 Future Trends
    • 4.4.1 Growing Importance of Packing Density
  • 4.5 Impact of Drivers and Restraints:

5. Peripheral Embolization Coils Market - North America Analysis

  • 5.1 North America Peripheral Embolization Coils Market Overview
  • 5.2 Peripheral Embolization Coils Market Revenue (US$ Million), 2021-2031
  • 5.3 Peripheral Embolization Coils Market Forecast Analysis
  • 5.4 Peripheral Embolization Coils Market: Company Positioning

6. North America Peripheral Embolization Coils Market Analysis - by Product Type

  • 6.1 Overview
  • 6.2 Detachable Coil
    • 6.2.1 Overview
    • 6.2.2 Detachable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Pushable Coil
    • 6.3.1 Overview
    • 6.3.2 Pushable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

7. North America Peripheral Embolization Coils Market Analysis - by Material

  • 7.1 Overview
  • 7.2 Platinum
    • 7.2.1 Overview
    • 7.2.2 Platinum: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Platinum & Hydrogel
    • 7.3.1 Overview
    • 7.3.2 Platinum & Hydrogel: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Platinum Tungsten Alloy
    • 7.4.1 Overview
    • 7.4.2 Platinum Tungsten Alloy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Peripheral Embolization Coils Market Analysis - by Application

  • 8.1 Overview
  • 8.2 Bleedings & Trauma
    • 8.2.1 Overview
    • 8.2.2 Bleedings & Trauma: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Malformations
    • 8.3.1 Overview
    • 8.3.2 Malformations: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Tumors
    • 8.4.1 Overview
    • 8.4.2 Tumors: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Visceral Aneurysms
    • 8.5.1 Overview
    • 8.5.2 Visceral Aneurysms: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.6 Endoleak Type II
    • 8.6.1 Overview
    • 8.6.2 Endoleak Type II: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.7 Varicose Veins
    • 8.7.1 Overview
    • 8.7.2 Varicose Veins: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Peripheral Embolization Coils Market - Country Analysis

  • 9.1 North America Overview
    • 9.1.1 North America: Peripheral Embolization Coils Market Breakdown, by Key Country, 2023 and 2031 (%)
      • 9.1.1.1 United States: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.1.1 United States: Peripheral Embolization Coils Market Breakdown, by Product Type
        • 9.1.1.1.2 United States: Peripheral Embolization Coils Market Breakdown, by Material
        • 9.1.1.1.3 United States: Peripheral Embolization Coils Market Breakdown, by Application
      • 9.1.1.2 Canada: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.2.1 Canada: Peripheral Embolization Coils Market Breakdown, by Product Type
        • 9.1.1.2.2 Canada: Peripheral Embolization Coils Market Breakdown, by Material
        • 9.1.1.2.3 Canada: Peripheral Embolization Coils Market Breakdown, by Application
      • 9.1.1.3 Mexico: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.3.1 Mexico: Peripheral Embolization Coils Market Breakdown, by Product Type
        • 9.1.1.3.2 Mexico: Peripheral Embolization Coils Market Breakdown, by Material
        • 9.1.1.3.3 Mexico: Peripheral Embolization Coils Market Breakdown, by Application

10. Peripheral Embolization Coils Market - Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the Peripheral Embolization Coils Market
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Medtronic Plc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Penumbra, Inc.
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Balt
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Boston Scientific Corp
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Cook Medical Holdings LLC
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Wallaby Medical
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Spartan Micro Inc.
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Terumo Corp
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms